Gabapentin
Rank #61 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$291.0M
Total Cost
15,142,335
Total Claims
$291.0M
Total Cost
158,635
Prescribers
$19
Cost per Claim
3,929,716
Beneficiaries
23,679,693
30-Day Fills
$1,835
Avg Cost/Provider
95
Avg Claims/Provider
Share of Medicare Part D Spending
0.11%
of total Medicare Part D spending
$291.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $291.0M total
🔎 Data Overview
At $19.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Gabapentin
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Marina Neystat | Neurology | Forest Hills, NY | 462 | $250K |
| 2 | Irving Haber | Physical Medicine and Rehabilitation | Terre Haute, IN | 114 | $155K |
| 3 | Oliver James | Pain Management | Lexington, KY | 8,188 | $127K |
| 4 | Maria Dolgovina | Neurology | Forest Hills, NY | 184 | $117K |
| 5 | Elvira Kamenetsky | Neurology | Brooklyn, NY | 278 | $109K |
| 6 | David Bosomworth | Pain Management | Frankfort, KY | 6,678 | $103K |
| 7 | Isabel Mendoza | Family Practice | Darlington, SC | 61 | $103K |
| 8 | Christopher Lyon | Internal Medicine | Lexington, KY | 5,772 | $102K |
| 9 | Ricky Tubbs | Anesthesiology | Gardendale, AL | 4,797 | $81K |
| 10 | Alpesh Patel | Interventional Pain Management | Baton Rouge, LA | 3,280 | $72K |
| 11 | Isaac Snapp | Physician Assistant | Darlington, SC | 48 | $70K |
| 12 | Terence Frinks | Family Practice | Tucker, GA | 5,246 | $67K |
| 13 | Andrew Graf | Internal Medicine | Plymouth Meeting, PA | 4,234 | $66K |
| 14 | Dina Liberman | Internal Medicine | Brooklyn, NY | 90 | $66K |
| 15 | Idan Sharon | Neurology | Brooklyn, NY | 88 | $65K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 58 | Sitagliptin Phos/Metformin Hcl (Janumet) | $302.2M | 329,315 |
| 59 | Tofacitinib Citrate (Xeljanz Xr) | $294.4M | 49,478 |
| 60 | Umeclidinium Brm/Vilanterol Tr (Anoro Ellipta) | $294.3M | 480,651 |
| 61 | Gabapentin (Gabapentin) | $291.0M | 15,142,335 |
| 62 | Cabozantinib S-Malate (Cabometyx) | $287.3M | 11,285 |
| 63 | Rsv Vacc, Pref A And Pref B/Pf (Abrysvo) | $284.5M | 872,396 |
| 64 | Bimatoprost (Lumigan) | $284.4M | 610,243 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology